Clinical Trials on Angiokeratoma
Total 1 results
-
CENTOGENE GmbH RostockWithdrawnChronic Kidney Disease | Hearing Loss | Angiokeratomas | Ocular AbnormalitiesSri Lanka, India, Germany
Sponsors and Collaborators
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- University Medical Center Goettingen
- Caritas Freetown
- Victor Montori
- Elim Pediatric Pharmaceuticals Inc.
- Rui-hua Xu, MD, PhD
- Donders Institute for Brain, Cognition and Behavior
- Fondren Orthopedic Group L.L.P.
- Cardresearch
- Norsk Proteinintolerance, Norway
- San MediTech(Huzhou)Co.,Ltd.
- AMTC & Associates
- CRMBM-CEMEREM
- Alberta Children's Hospital, Calgary, Canada
- Diego Hernan Giunta, MD
- ProteoSys AG
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- The Fifth Affiliated Hospital of Zunyi Medical College
- Societa Italiana di Endoscopia Digestiva
- Celtaxsys Aus Pty Limited
- View Full List
Medical Conditions
- Malignant Ascites Due to Epithelial Carcinoma
- Lymphedema of Arm
- Normal Diameter of Optic Nerve
- Fever, Sweats, and Hot Flashes
- Prostate Cancer Recurrent
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Gynecologic Cancer
- Stereotactic Radioablation for Ventricular Tachycardia
- Spermatogenesis Arrest
- Postcomatose Unawareness State
- Non-dystrophic Myotonias
- Tube Disorders Eustachian
- Disturbance of Activity and Attention
- Orbital Tumor
- Atrial Fibrillation, Postoperative
- Plasmodium Falciparum Malaria (Drug Resistant)
- Auditory Hallucination, Verbal
- Non-compressible Torso Hemorrhage
- Fibromyalgia Syndrome, Primary
- Tularaemia
- View Full List
Drug Interventions
- Topotecan
- SERETIDE Diskus
- Methotrexate
- Flibanserin 100 mg dose every evening
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Insulin
- Cetrorelix 78 mg + 78 mg
- Enzalutamide, Abiraterone
- Mupirocin Calcium
- Epimedium Prenylflavonoids Extract
- Atezolizumab
- Polyethylene glycol 3350
- Ruxolitinib
- Oxycodone, fentanyl
- Cytarabine ARA-C
- Indoximod
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Lamivudine
- PF-00868554
- Bortezomib/dexamethasone
- View Full List
CROs by country
- Contract Research Organizations in Argentina
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Canada
- Contract Research Organizations in China
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Kenya
- Contract Research Organizations in Latvia
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Panama
- Contract Research Organizations in Türkiye
- Contract Research Organizations in Vietnam
- CRO list by country